A Study of Chemoradiation in Combination with Tislelizumab As First Line Treatment in Participants with Advanced Esophageal Squamous Cell Carcinoma
Clinical trial NCT05919030 · RECRUITING
Trial details
- NCT number
- NCT05919030
- Sponsor
- Renmin Hospital of Wuhan University
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-01
- Primary completion
- 2026-07-01
- Enrollment
- 155
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.